US Patent 8846918 Compounds useful as inhibitors of ATR kinase

Patent 8846918 was granted and assigned to Vertex Pharmaceuticals on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Vertex Pharmaceuticals

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88469180

Patent Inventor Names

David Kay0

Jean-Damien Charrier0

Date of Patent

September 30, 2014

Patent Application Number

136729580

Date Filed

November 9, 2012

Patent Citations Received

‌

US Patent 11787781 Inhibiting ataxia telangiectasia and RAD3-related protein (ATR)

‌

US Patent 11926616 Aminopyrazine diol compounds as PI3K-γ inhibitors

Patent Primary Examiner

‌

Wu-Cheng Winston Shen

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8846918 Compounds useful as inhibitors of ATR kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API